£72.56

Springer Hepatitis C Virus Treatment: Highly Effective Therapy with Direct Acting Antivirals and Associated Viral Resistance

White

Price data last checked 91 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

This is the most expensive it has ever been. Walk away.

£73 today · previous high £73 · all-time low £53

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 640 days • 640 data points (No recent data available)

Historical
Generating forecast...
£72.56 £51.11 £55.79 £60.47 £65.15 £69.83 £74.51 09 June 2024 15 November 2024 24 April 2025 01 October 2025 10 March 2026

Price Distribution

Price distribution over 640 days • 5 price levels

Days at Price
Current Price
20 days 14 days 163 days 430 days · current 13 days · current 0 108 215 323 430 £53 £64 £71 £72 £73 Days at Price

Price Analysis

Most common price: £72 (430 days, 67.2%)

Price range: £53 - £73

Price levels: 5 different prices over 640 days

Description

This book introduces readers to Direct Acting Antiviral (DAAs) agents, newly developed drugs to treat chronic hepatitis C virus infection, which have an excellent anti-viral effect on virus replication. These drugs have been developed to enhance the effect of interferon and ribavirin, as the resistant strains against each drug have been described both in vitro and in vivo and the existences of naturally occurring variants have been reported. However, since the combination of different classes of DAAs is sufficient to completely eradicate the virus without the need for interferon or ribavirin, the current treatment regimen does not include interferon. Ribavirin is used in combination with sofosbuvir, a potent polymerase inhibitor, to enhance its antiviral effects. Hepatitis C Virus Treatment offers readers a comprehensive guide to hepatitis C; describing the resistance profiles against these drugs and shedding light on the difficulties involved in DAA therapy and the direction of future treatments, it will equip doctors to understand the essentials of treating the disease. It also describes in detail new and innovative DAA treatments, the effects of the agents, and the characteristics of resistance, providing cutting-edge information not only for hepatologists, but also for researchers, clinical residents, and medical students.

Product Specifications

Colour
White
Format
Hardcover
Domain
Amazon UK
Release Date
14 November 2016
Listed Since
16 July 2016

Barcode

No barcode data available

Similar Products You Might Like

Hepatitis C Virus II: Infection and Disease: 2
98% match

Hepatitis C Virus II: Infection and Disease: 2

Springer

£128.12 28 Feb 2026
Hepatitis C Virus II: Infection and Disease: 2
98% match

Hepatitis C Virus II: Infection and Disease: 2

Springer

£128.34 02 Feb 2026
Hepatitis C: Antiviral Drug Discovery and Development
98% match

Hepatitis C: Antiviral Drug Discovery and Development

Caister Academic Press Limited

£218.97 24 Jan 2026
Overcoming Barriers to Eliminate Hepatitis C, An Issue of Infectious Disease Clinics of North America (Volume 32-2) (The Clinics: Internal Medicine, Volume 32-2)
97% match

Overcoming Barriers to Eliminate Hepatitis C, An Issue of Infectious Disease Clinics of North America (Volume 32-2) (The Clinics: Internal Medicine, Volume 32-2)

Elsevier

£73.86 09 Mar 2026
Hepatitis C Virus Disease: Immunobiology and Clinical Applications
97% match

Hepatitis C Virus Disease: Immunobiology and Clinical Applications

Springer

£107.32 12 Dec 2025
Current Management of Hepatitis C Virus, An Issue of Clinics in Liver Disease (Volume 19-4) (The Clinics: Internal Medicine, Volume 19-4)
97% match

Current Management of Hepatitis C Virus, An Issue of Clinics in Liver Disease (Volume 19-4) (The Clinics: Internal Medicine, Volume 19-4)

Elsevier

£68.41 20 Apr 2026
Novel and Combination Therapies for Hepatitis C Virus, An Issue of Clinics in Liver Disease (Volume 17-1) (The Clinics: Internal Medicine, Volume 17-1)
97% match

Novel and Combination Therapies for Hepatitis C Virus, An Issue of Clinics in Liver Disease (Volume 17-1) (The Clinics: Internal Medicine, Volume 17-1)

Elsevier

£54.14 08 Mar 2026
Chronic Hepatitis C Virus: Advances in Treatment, Promise for the Future
97% match

Chronic Hepatitis C Virus: Advances in Treatment, Promise for the Future

Springer

£100.10 08 Feb 2026
Hepatitis C Virus: From Molecular Virology to Antiviral Therapy: 369 (Current Topics in Microbiology and Immunology, 369)
97% match

Hepatitis C Virus: From Molecular Virology to Antiviral Therapy: 369 (Current Topics in Microbiology and Immunology, 369)

Springer

£107.32 12 Jan 2026
Hepatitis C: Methods and Protocols: 510 (Methods in Molecular Biology, 510)
97% match

Hepatitis C: Methods and Protocols: 510 (Methods in Molecular Biology, 510)

Humana

£102.16 18 Apr 2026
Novel Therapies in Hepatitis C Virus, An Issue of Clinics in Liver Disease (Volume 13-3) (The Clinics: Internal Medicine, Volume 13-3)
97% match

Novel Therapies in Hepatitis C Virus, An Issue of Clinics in Liver Disease (Volume 13-3) (The Clinics: Internal Medicine, Volume 13-3)

Saunders

£53.98 01 Mar 2026
Hepatitis C Infection as a Systemic Disease:Extra-HepaticManifestation of Hepatitis C, An Issue of Clinics in Liver Disease (Volume 21-3) (The Clinics: Internal Medicine, Volume 21-3)
97% match

Hepatitis C Infection as a Systemic Disease:Extra-HepaticManifestation of Hepatitis C, An Issue of Clinics in Liver Disease (Volume 21-3) (The Clinics: Internal Medicine, Volume 21-3)

Elsevier

£68.52 27 Feb 2026
Chronische Virushepatitis und ihre Behandlung mit Interferon alfa
97% match

Chronische Virushepatitis und ihre Behandlung mit Interferon alfa

Springer

£43.09 18 Apr 2026
Hepatitis C: State of the Art at the Millennium: A Bound Compilation of Issues 1 and 2 of Seminars in Liver Disease (2000)
96% match

Hepatitis C: State of the Art at the Millennium: A Bound Compilation of Issues 1 and 2 of Seminars in Liver Disease (2000)

Thieme

£76.93 15 Apr 2026
The Molecular Medicine of Viral Hepatitis (Molecular Medical Science Series)
96% match

The Molecular Medicine of Viral Hepatitis (Molecular Medical Science Series)

Wiley-Blackwell

£75.00 28 Feb 2026
A National Strategy for the Elimination of Hepatitis B and C: Phase Two Report
96% match

A National Strategy for the Elimination of Hepatitis B and C: Phase Two Report

National Academies Press

£95.92 19 Apr 2026
Chronic Viral Hepatitis: Management and Control
96% match

Chronic Viral Hepatitis: Management and Control

Foster Academics

£72.50 04 Mar 2026
Hepatitis C Virus: From Laboratory to Clinic
96% match

Hepatitis C Virus: From Laboratory to Clinic

Cambridge University Press

£61.52 05 Mar 2026
Hepatitis B Virus and Liver Disease
96% match

Hepatitis B Virus and Liver Disease

£100.57 15 Dec 2025
HCV: The Journey from Discovery to a Cure: Volume I: 31 (Topics in Medicinal Chemistry, 31)
96% match

HCV: The Journey from Discovery to a Cure: Volume I: 31 (Topics in Medicinal Chemistry, 31)

Springer

£250.00 30 Jan 2026
HCV: The Journey from Discovery to a Cure: Volume I: 31 (Topics in Medicinal Chemistry, 31)
96% match

HCV: The Journey from Discovery to a Cure: Volume I: 31 (Topics in Medicinal Chemistry, 31)

£261.47 07 Jan 2026
The Hepatitis C Viruses: 242 (Current Topics in Microbiology and Immunology, 242)
96% match

The Hepatitis C Viruses: 242 (Current Topics in Microbiology and Immunology, 242)

Springer

£77.05 05 Mar 2026
Hepatitis Viruses
96% match

Hepatitis Viruses

Springer

£109.57 07 Feb 2026
Silymarin protection role in modulating ribavirin genotoxicity: Evaluation of the antioxidant silymarin role in modulating the in vivo genotoxicity of the antiviral drug ribavirin
96% match

Silymarin protection role in modulating ribavirin genotoxicity: Evaluation of the antioxidant silymarin role in modulating the in vivo genotoxicity of the antiviral drug ribavirin

LAP Lambert Academic Publishing

£55.00 14 Apr 2026